Cell therapy developers, especially early-stage companies, often face significant challenges scaling their manufacturing processes, requiring extensive investment in developing their own methods ...

Cabaletta Bio is getting set to launch a clinical trial testing its cell therapy resecabtagene autoleucel (rese-cel) in people with relapsing and progressive forms of multiple sclerosis (MS).

Cerebras Systems (a client of Cambrian-AI Research) announced a new foundation model co-developed with partner The Mayo Clinic, that can identify the best medical therapy for Rheumatoid Arthritis.

Cerebras Systems’ calculations can determine which treatment will work on a given patient with rheumatoid arthritis. Building on Mayo Clinic’s leadership in precision medicine, the model is ...

1 Department of Rheumatology and Immunology, Qinzhou First People's Hospital, Qinzhou, Guangxi, China 2 Minda Hospital of Hubei Minzu University, Enshi, China Cell therapy is an emerging strategy for ...

In July last year, he flew to Kuala Lumpur to undergo stem cell therapy for both knees at a private clinic ... performed more than 1,000 stem cell procedures to regenerate knee cartilage ...

UCSF scientists have discovered a new type of stem ... clinic and laboratory can now be tested against this hard data, and we’re excited to see what else the field can do with it.” These samples, ...

which use the patient’s stem cells in the treatment, and allogeneic therapies, which are not personalized for a single patient. “We’ve seen big breakthroughs where these treatments have ...

Pluripotent stem cells are cells that have the capacity to self-renew by dividing and to develop into the three primary germ cell layers of the early embryo and therefore into all cells of the ...

Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%.